Somatostatin inhibits Ca(2+)-activated K+ channels in human colonic crypts.
Butterfield
I
I
Department of Medicine, University of Manchester, Hope Hospital, Salford, U.K.
Warhurst
G
G
Sandle
G I
GI
D002118:Calcium / Q000494:pharmacology*; D002462:Cell Membrane / Q000502:physiology; D003106:Colon / Q000502:physiology*; D006801:Humans; D007413:Intestinal Mucosa / Q000502:physiology*; D018408:Patch-Clamp Techniques; D026902:Potassium Channel Blockers; D015221:Potassium Channels / Q000502:physiology*; D013004:Somatostatin / Q000494:pharmacology*; D019284:Thapsigargin / Q000494:pharmacology
D026902:Potassium Channel Blockers; D015221:Potassium Channels; D013004:Somatostatin; D019284:Thapsigargin; D002118:Calcium